combination therapy that contains two diabetes medicines, linagliptin and metformin.Linagliptin belongs to a class of medicines called DPP-4 inhibitors, and metformin belongs to a class of medicines called biguanides.
Benefits
improve glycaemic control in patients with type 2 diabetes
How To Use
improve glycaemic control in patients with type 2 diabetes:improve glycaemic control in patients with type 2 diabetes:
Features
Ingredients
Linagliptin 2.5mg, Metformin hydrochloride 1000mg
Indication
Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus, Polycystic Ovary Syndrome (Pcos)
